Lung Diseases, Interstitial
Information
- Disease name
- Lung Diseases, Interstitial
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT05285982 | Active, not recruiting | Phase 3 | A Study to Evaluate Long-term Safety of Nintedanib in Children and Adolescents With Interstitial Lung Disease (InPedILD®-ON) | April 4, 2022 | August 11, 2025 |
| NCT05867914 | Active, not recruiting | N/A | Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD | December 4, 2023 | March 29, 2024 |
| NCT04325217 | Active, not recruiting | Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan | April 15, 2020 | September 30, 2026 | |
| NCT05321082 | Active, not recruiting | Phase 3 | A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs) | October 5, 2022 | March 19, 2025 |
| NCT04702893 | Active, not recruiting | INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation | May 28, 2021 | June 30, 2024 | |
| NCT04559581 | Active, not recruiting | Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan | September 28, 2020 | December 31, 2024 | |
| NCT03747627 | Active, not recruiting | BPF Genetics of ILD Study | January 19, 2019 | January 1, 2028 | |
| NCT04283994 | Active, not recruiting | N/A | Project to Improve Communication About Serious Illness--Hospital Study: Comparative Effectiveness Trial (Trial 2) | July 26, 2021 | August 1, 2025 |
| NCT03843892 | Approved for marketing | An Expanded Access Program to Provide Nintedanib to Patients With Non-IPF ILD Who Have no Alternative Treatment Possibilities | |||
| NCT00005317 | Completed | Idiopathic Pulmonary Fibrosis--Pathogenesis and Staging - SCOR in Occupational and Immunological Lung Diseases | December 1986 | November 1996 | |
| NCT02370693 | Completed | Phase 2 | Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis | March 2016 | January 1, 2020 |
| NCT05957198 | Completed | Oxygen Therapy Use in Patients With Fibrotic Interstitial Lung Disease | July 25, 2023 | September 26, 2023 | |
| NCT02464592 | Completed | N/A | Diagnostic Yield and Safety of Transbronchial Lung Biopsy Using Cryoprobes Versus Conventional Forceps. A Multicenter Study | April 2014 | August 2017 |
| NCT02501668 | Completed | The Prevalence of Lung Cancer in Patients With Interstitial Lung Disease | July 2015 | July 2015 | |
| NCT05875532 | Completed | Study of Progression to Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Incidence/Management and Treatment | April 20, 2023 | May 1, 2023 | |
| NCT00014859 | Completed | Epidemiology of Surfactant Protein-B Deficiency | June 1, 2001 | April 26, 2024 | |
| NCT02858180 | Completed | Phase 4 | Hepatitis C Virus(HCV) Heart and Lung Study | December 2016 | July 4, 2019 |
| NCT02879773 | Completed | Computed Tomography Assessment of Regional Ventilation (CURVE) | January 22, 2016 | July 31, 2019 | |
| NCT02999178 | Completed | Phase 3 | Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) | January 17, 2017 | August 12, 2019 |
| NCT05855447 | Completed | Muscles Oxygenation During Exercise in Fibrosing Interstitial Lung Diseases | February 13, 2023 | October 1, 2023 | |
| NCT00027235 | Completed | Popcorn Lung: the Discovery of a New Disease | |||
| NCT03136120 | Completed | Cryobiopsy Study to Assess Drug Distribution in Subjects With Suspected Interstitial Lung Disease | November 21, 2017 | November 13, 2018 | |
| NCT03313180 | Completed | Phase 3 | A Trial to Evaluate the Safety of Long Term Treatment With Nintedanib in Patients With Scleroderma Related Lung Fibrosis | November 27, 2017 | January 25, 2023 |
| NCT00016627 | Completed | Linkage Study in Familial Pulmonary Fibrosis | August 2000 | July 2005 | |
| NCT05719233 | Completed | Assessment of Neuropsychiatric Function in Patients With Interstitial Lung Disease | October 1, 2022 | December 1, 2023 | |
| NCT05396469 | Completed | Using Thoracic Ultrasound to Detect Interstitial Lung Disease in Patients With Rheumatoid Arthritis | June 10, 2022 | June 2, 2023 | |
| NCT03816722 | Completed | N/A | High Flow in Interstitial Lung Disease | February 15, 2019 | June 30, 2021 |
| NCT03820726 | Completed | Phase 3 | A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD) | April 16, 2019 | August 30, 2022 |
| NCT03099187 | Completed | Phase 2 | A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease | May 15, 2017 | January 10, 2020 |
| NCT04281784 | Completed | N/A | Project to Improve Communication About Serious Illness--Hospital Study: Pragmatic Trial (Trial 1) | April 23, 2020 | September 26, 2022 |
| NCT04630743 | Completed | N/A | Cognitive and Behavioral Intervention for the Management of Episodic Breathlessness in Patients With Advanced Disease | February 9, 2019 | March 15, 2020 |
| NCT06383819 | Completed | Phase 3 | Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 | April 8, 2022 | December 31, 2023 |
| NCT01374542 | Completed | Respiratory Endoscopy: Diagnostic Yield, Technical Factors and Complications | June 2011 | January 1, 2021 | |
| NCT01442779 | Completed | Phase 2 | Clinical Trial of Low Dose Oral Interferon Alpha in Idiopathic Pulmonary Fibrosis | September 2000 | May 2007 |
| NCT01553981 | Completed | Phase 3 | A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma | March 2012 | May 2014 |
| NCT02125916 | Completed | N/A | Evaluating the Effect of Oxygentherapy on Concentration at Chronic Lung Patients | July 2014 | |
| NCT02251964 | Completed | Phase 2/Phase 3 | Rituximab in Interstitial Pneumonitis | September 2014 | February 2018 |
| NCT04016168 | Completed | Idiopathic Pulmonary Fibrosis and Serum Bank | October 22, 2014 | December 28, 2022 | |
| NCT04093024 | Completed | Phase 3 | A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD) | December 3, 2019 | May 24, 2022 |
| NCT05065190 | Completed | Phase 3 | A Study to Test How Well a Medicine Called Nintedanib Helps People in China With Progressive Lung Fibrosis | November 25, 2021 | May 7, 2024 |
| NCT04739150 | No longer available | An Expanded Access Program in Belgium to Provide Nintedanib to People With Lung Diseases Called Non-IPF ILDs Who Have no Alternative Treatment Options | |||
| NCT06385301 | Not yet recruiting | N/A | Exercise Performance on Ambient Air vs. Low-Flow Oxygen Therapy With Chronic Lung Diseases | May 2024 | November 2025 |
| NCT05819385 | Not yet recruiting | Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) Epidemiology Non-interventional Study (NIS) | June 24, 2024 | October 17, 2026 | |
| NCT06122233 | Not yet recruiting | N/A | REBUILD-SM Study for People With Interstitial Lung Disease (ILD) | May 2024 | August 2027 |
| NCT06325696 | Not yet recruiting | Phase 2 | H01 in Adults With Interstitial Lung Disease (The SOLIS Study) | June 23, 2024 | December 31, 2025 |
| NCT06440746 | Recruiting | Phase 2/Phase 3 | Efficacy and Safety of Olokizumab in Patients With Progressive Fibrosing Interstitial Lung Diseases | August 23, 2023 | December 5, 2026 |
| NCT00258583 | Recruiting | Dorothy P. and Richard P. Simmons Center for ILD Research Registry | October 2003 | July 2035 | |
| NCT02369575 | Recruiting | Identification of Novel Markers of Human Lung Disease | February 2015 | February 2030 | |
| NCT02852928 | Recruiting | European Management Platform for Childhood Interstitial Lung Diseases - chILD-EU Register and Biobank | December 2013 | December 2029 | |
| NCT03561818 | Recruiting | N/A | Comparison of PR Efficiency in Home-based With Hospital-based PR in Bronchiectasis | June 19, 2018 | December 30, 2024 |
| NCT04170062 | Recruiting | N/A | Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest | December 15, 2020 | December 31, 2024 |
| NCT04195789 | Recruiting | Assessment of Interstitial Lung Disease in Rheumatoid Arthritis by Lung Ultrasound | August 4, 2020 | May 4, 2026 | |
| NCT04707781 | Recruiting | Database for Interstitial Lung Disease | May 1, 2021 | January 31, 2026 | |
| NCT04807114 | Recruiting | A Single-cell Approach to Identify Biomarkers of Efficacy and Toxicity for ICI in NSCLC | February 1, 2020 | January 31, 2024 | |
| NCT04930666 | Recruiting | BREATHE ALD: A Shared Decision-Making Intervention for Adults With Advanced Lung Disease | November 10, 2021 | December 2024 | |
| NCT05151640 | Recruiting | INCHANGE - Nintedanib for Changes in Cough and Dyspnea in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation | September 26, 2022 | June 30, 2025 | |
| NCT05492994 | Recruiting | N/A | A Study to Test Different Imaging Techniques in Patients With Different Types of Interstitial Lung Disease | December 16, 2022 | January 20, 2026 |
| NCT05503030 | Recruiting | Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients | November 1, 2022 | December 30, 2026 | |
| NCT05596760 | Recruiting | N/A | Promoting Goals-of-Care Discussions for Patients With Memory Problems and Their Caregivers | September 11, 2023 | July 2027 |
| NCT05722340 | Recruiting | N/A | NIVATS Versus IGAVATS: a Pilot Trial Addressing Biopsy Quality in Undetermined Interstitial Lung Diseases | May 24, 2023 | November 24, 2025 |
| NCT05854563 | Recruiting | Cough Capture as a Portal Into the Lung | March 28, 2023 | June 2024 | |
| NCT05855109 | Recruiting | Developing a Screening Tool for Interstitial Lung Disease in People With Rheumatoid Arthritis Using Risk Factors | October 17, 2023 | May 28, 2025 | |
| NCT05866198 | Recruiting | N/A | Physical Activity and Quality of Life in Fibrotic Lung Diseases After Initiating Anti-fibrotic Therapy and Pulmonary Rehabilitation | September 1, 2023 | May 2026 |
| NCT04119115 | Terminated | Integrated Radiographic and Metabolomics Risk Assessment in Patients With Interstitial Lung Diseases | September 30, 2021 | October 20, 2022 | |
| NCT03043898 | Terminated | Mapping Sound Propagation Through the Human Lung for Better Diagnosis | February 14, 2018 | April 23, 2020 | |
| NCT00005290 | Terminated | Epidemiology of Interstitial Lung Disease | April 1988 | June 1997 | |
| NCT01203943 | Terminated | Phase 2 | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF) | January 1, 2011 | August 24, 2012 |
| NCT03142191 | Terminated | Phase 2 | A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis | July 26, 2017 | December 24, 2021 |
| NCT01432080 | Terminated | Phase 2 | Steroids, Azithromycin, Montelukast, and Symbicort (SAMS) for Viral Respiratory Tract Infection Post Allotransplant | September 2011 | December 30, 2013 |
| NCT00005295 | Terminated | Idiopathic Pulmonary Fibrosis: a Case-control Study | July 1989 | June 1995 | |
| NCT04159129 | Unknown status | Effects of Pulmonary Rehabilitation on Walking Speed in Patients With COPD or ILD Patients | November 7, 2019 | July 31, 2020 | |
| NCT04100226 | Unknown status | N/A | Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD). | March 1, 2019 | January 1, 2020 |
| NCT02705144 | Unknown status | Definition of the Status of the Human Lung Stem Cell Niches ex Vivo in Tissue Biopsies Performed in Patients With Emphysema and Interstitial Fibrosis | March 2016 | March 2019 | |
| NCT03995654 | Unknown status | Research of Burden of Interstititial Lung Diseases in Turkey | January 1, 2019 | May 1, 2021 | |
| NCT03718780 | Unknown status | N/A | Assessment of Continuous Measurement of Transcutaneous CO2 for Evaluation of Alveolar Dead Space During Exercise | February 22, 2019 | February 22, 2024 |
| NCT03858842 | Unknown status | Non-interventional Study Describing Epidemiology, Prognosis and Patient Healthcare Costs in France, 2010-2017 | March 2019 | December 2019 | |
| NCT02543073 | Unknown status | Phase 1/Phase 2 | MSC for Treatment of Interstitial Lung Disease After Allo-HSCT | September 2014 | June 2018 |
| NCT02377739 | Unknown status | N/A | Non-invasive Ventilation in Patients With Interstitial Lung Disease - a Feasibility Study | February 2015 | December 2019 |
| NCT03596528 | Unknown status | N/A | Interstitial Lung Disease (ILD). Diagnostic Yield of Surgical Lung Biopsy Versus Cryobiopsy in the Same Surgical Stage. | March 23, 2018 | December 31, 2018 |
| NCT00841750 | Unknown status | Phase 3 | Chest Tube After a Video-assisted Thoracoscopic Surgery Pulmonary Wedge Resection | July 2008 | June 2012 |
| NCT04354220 | Unknown status | Capnography Monitoring in Ventilated Children | June 9, 2020 | December 31, 2023 | |
| NCT04650659 | Unknown status | Functional Exercise Tests in Patients With Systemic Sclerosis | July 27, 2021 | January 31, 2023 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D017563